Skip to main content
Log in

In vitro susceptibility of thirtyBorrelia strains from various sources against eight antimicrobial chemotherapeutics

In vitro-Empfindlichkeit von 30Borrelia-Stämmen gegenüber acht Antibiotika

  • Special Addendum — Part I
  • Therapy And Prophylaxis In Lyme Borreliosis
  • Published:
Infection Aims and scope Submit manuscript

Summary

Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) were evaluated of the antimicrobial chemotherapeutics amoxicillin, azithromycin, cefotaxime, ceftriaxone, doxycycline, penicillin G sodium, roxithromycin, and trimethoprim-sulfamethoxazole for 30Borrelia strains from various sources (skin, cerebrospinal fluid, ticks). Of these strains 29 were Lyme disease agents of the speciesBorrelia afzelii (n=12),Borrelia burgdorferi sensu stricto (n=4),Borrelia garinii (n=13), and one was the relapsing fever strainBorrelia turicatae (n=1). Tests were performed in microtiter plates by broth dilution. MIC was determined after 72 hours of incubation by comparing growth control with the antibiotic dilutions by means of dark field microscopy. Strains tested were susceptible against amoxicillin, azithromycin, cefotaxime, ceftriaxone, doxycycline, and penicillin G sodium, partly susceptible to roxithromycin, and resistant to trimethoprimsulfamethoxazole. No statistically significant differences in MIC and MBC were seen among the different antibiotics with the variousBorrelia species.

Zusammenfassung

Minimale Hemmkonzentrationen (MHK), und Minimale bakterizide Konzentrationen der Antibiotika Amoxicillin, Azithromycin, Cefotaxim, Ceftriaxon, Doxycyclin, Penicillin G Natrium, Roxithromycin und Trimethoprim-Sulfamethoxazol (Cotrimoxazol) gegenüber 30 Borrelia-Stämmen verschiedener Herkunft (Haut, Liquor cerebrospinalis, Zecken) wurden im Bouillonverdünnungstest in Mikrotiterplatten bestimmt. Von den Borrelienstämmen, die in dieser Studie verwendet worden sind, waren 29 Erreger der Lyme-Borreliose und zwar die SpeciesBorrelia afzelii (n=12),Borrelia burgdorferi sensu stricto (n=4),Borrelia garinii (n=13), und einer war der RückfallfieberstammBorrelia turicatae (n=1). Die MHK wurde nach 72stündiger Inkubation mittels Dunkelfeldmikroskopie bestimmt, indem die Wachstumskontrollen mit den Antibiotikaverdünnungen verglichen wurden. Die getesteten Stämme waren empfindlich gegenüber Amoxicillin, Azithromycin, Cefotaxim, Ceftriaxon, Doxycyclin und Penicillin G, zum Teil empfindlich gegenüber Roxithromycin und resistent gegenüber Cotrimoxazol. Statistisch gesicherte Unterschiede zwischen den MHK- und MBK-Werten der verschiedenen Antibiotika mit den verschiedenen Borrelien-Stämmen und -Arten konnten nicht gesichert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Steere, A. C., Hutchinson, G. J., Rahn, D. W., Sigal, L. H., Craft, J. E., De Sanna, E. T. Treatment of the early manifestations of Lyme disease. Ann. Intern. Med. 99 (1983) 22–26.

    PubMed  Google Scholar 

  2. Steere, A. C., Green, J., Schoen, R. T., Taylor, E., Hutchinson, G. J., Rahn, D. W. Successful parenteral therapy of established Lyme disease. N. Engl. J. Med. 312 (1985) 869–874.

    PubMed  Google Scholar 

  3. Kristoferitsch, W., Baumhackl, U., Sluga, E., Stanek, G., Zeiler, K. High dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zbl. Bakt. Mikrobiol. Hyg. A 263 (1986) 357–364.

    Google Scholar 

  4. Barbour, A. G. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57 (1984) 71–75.

    Google Scholar 

  5. Weber, K., Neubert, U., Thurmayr, R. Antibiotic therapy in early erythema migrans disease and related disorders. Zbl. Bakt. Mikrobiol. Hyg. A 263 (1986) 377–388.

    Google Scholar 

  6. Frautschi von Saanen, C. Stellenwert der Penicillintherapie beim Erythema chronicum migrans in Hinblick auf Spätkomplikationen. Inaugural Dissertation an der Universität Bern, Schweiz 1988.

    Google Scholar 

  7. Hansen, K., Hovmark, A., Lebech, A. M., Olsson, K., Halkier-Sorensen, I., Olsson, I., Sorensen, L. Roxithromycin in Lyme borreliosis. Acta. Derm. Venereol. 72 (1992) 297–300.

    PubMed  Google Scholar 

  8. Preac-Mursic, V., Wilske, B., Schierz, G. EuropeanBorrelia burgdorferi isolated from humans and ticks. Culture conditions and antibiotic susceptibility. Zbl. Bakt. Mikrobiol. Hyg. A 263 (1986) 112–118.

    Google Scholar 

  9. Baranton, G., Postic, D., Saint Girons, I., Boerlin, P., Piffaretti, J.-C., Assous, M., Grimiont, P. A. D. Delineation ofBorrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42 (1992) 378–383.

    PubMed  Google Scholar 

  10. Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Acta Path. Microbiol. Scand. Sect. B, Suppl. 217 (1971).

  11. Pfister, H. W., Preac Mursic, V., Wilske, B., Schielk, E., Sörgel, F., Einhäupl, K. M. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J. Infect. Dis. 163 (1991) 311–318.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stanek, G., Baradaran-Dilmaghani, R. In vitro susceptibility of thirtyBorrelia strains from various sources against eight antimicrobial chemotherapeutics. Infection 24, 60–63 (1996). https://doi.org/10.1007/BF01780660

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01780660

Keywords

Navigation